The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

From the 1Mayo Clinic, Jacksonville, Florida, 2Yale University School of Medicine, New
Haven, Connecticut, 3Cleveland Clinic Lerner College of Medicine of Case Western Reserve …

Cardiovascular implantable electronic devices (CIEDs) have evolved significantly since the
publication of the 2008 Heart Rhythm Society (HRS) consensus statement 1 outlining …

Background— Hypertrophic cardiomyopathy, a familial myocardial condition caused by
sarcomere protein mutations, is usually recognized by early adulthood. Hypertrophic …

Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for
selected patients in definable populations. The benefits and risks of ICD therapy are directly …

AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

… Patton, MD Kristen K. Patton …

Background— Atrial fibrillation (AF), the most common cardiac rhythm abnormality, is
associated with significant morbidity, mortality, and healthcare expenditures. Elevated B-type …

The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

Coronavirus disease 2019 (COVID-19) is a global pandemic that is wreaking havoc on the
health and economy of much of human civilization. Electrophysiologists have been impacted …